Encube Ethicals Private Limited — Clotrimazole Exporter Profile
Indian Pharmaceutical Exporter · #2 for Clotrimazole · $10.0M export value · DGFT Verified
Encube Ethicals Private Limited is the #2 Indian exporter of Clotrimazole with $10.0M in export value and 616 verified shipments. Encube Ethicals Private Limited holds a 10.8% market share in Clotrimazole exports across 10 countries. The company exports 11 pharmaceutical products worth $57.5M across 9 therapeutic categories.
Encube Ethicals Private Limited — Clotrimazole Export Profile: Buyers & Destinations
Where Does Encube Ethicals Private Limited Export Clotrimazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $4.5M | 272 | 43.5% |
| PHILIPPINES | $1.8M | 89 | 17.8% |
| UNITED STATES | $1.6M | 98 | 15.9% |
| THAILAND | $850.3K | 40 | 8.3% |
| KOREA,REPUBLIC OF | $333.7K | 24 | 3.3% |
| VIETNAM, DEMOCRATIC REP. OF | $326.7K | 13 | 3.2% |
| VIETNAM DEMOCRATIC REP. OF | $128.5K | 11 | 1.3% |
| HONG KONG | $126.2K | 22 | 1.2% |
| VIETNAM | $111.1K | 6 | 1.1% |
| REPUBLIC OF KOREA | $107.1K | 9 | 1.0% |
Encube Ethicals Private Limited exports Clotrimazole to 16 countries. The largest destination is AUSTRALIA accounting for 43.5% of Encube Ethicals Private Limited's Clotrimazole shipments, followed by PHILIPPINES (17.8%) and UNITED STATES (15.9%). These destinations reflect Encube Ethicals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clotrimazole from Encube Ethicals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BAYER AUTRALIA LIMITED | AUSTRALIA | $3.0M | 155 |
| PL DEVELOPMENTS | UNITED STATES | $1.1M | 72 |
| BAYER PHILIPPINES INC | PHILIPPINES | $1.1M | 49 |
| BAYER PHILIPPINES INC. | PHILIPPINES | $657.4K | 35 |
| NOUMED PHARMACEUTICALS PTY LTD, | AUSTRALIA | $643.4K | 58 |
| BAYER THAI CO.LTD. | THAILAND | $559.2K | 28 |
| BAYER KOREA LTD | KOREA,REPUBLIC OF | $440.9K | 33 |
| BAYER VIETNAM CO., LTD. | VIETNAM, DEMOCRATIC REP. OF | $375.3K | 16 |
| H2-PHARMA, LLC | UNITED STATES | $313.4K | 14 |
| NOUMED PHARMACEUTICALS PTY LIMITED | AUSTRALIA | $208.4K | 15 |
Encube Ethicals Private Limited supplies Clotrimazole to 44 buyers globally. The largest buyer is BAYER AUTRALIA LIMITED (AUSTRALIA), followed by PL DEVELOPMENTS (UNITED STATES) and BAYER PHILIPPINES INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clotrimazole Export Value and How Much Does Encube Ethicals Private Limited Contribute?
India exported $58.5M worth of Clotrimazole through 10,037 shipments from 712 suppliers to 158 countries, serving 1,728 buyers globally. Encube Ethicals Private Limited contributes $10.0M to this total, accounting for 10.8% of India's Clotrimazole exports. Encube Ethicals Private Limited ships Clotrimazole to 16 countries through 44 buyers.
What Is the Average Shipment Value for Encube Ethicals Private Limited's Clotrimazole Exports?
Encube Ethicals Private Limited's average Clotrimazole shipment value is $16.2K per consignment, based on 616 shipments totaling $10.0M. The largest destination is AUSTRALIA (43.5% of Encube Ethicals Private Limited's Clotrimazole exports).
How Does Encube Ethicals Private Limited Compare to Other Indian Clotrimazole Exporters?
Encube Ethicals Private Limited ranks #2 among 712 Indian Clotrimazole exporters with a 10.8% market share. The top 3 exporters are CAPLIN POINT LABORATORIES LIMITED ($12.0M), ENCUBE ETHICALS PRIVATE LIMITED ($10.0M), S KANT HEALTHCARE LIMITED ($7.2M). Encube Ethicals Private Limited processed 616 shipments to 10 destination countries.
What Clotrimazole Formulations Does Encube Ethicals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| P CODE- 86658291 CLOTRIMAZOLE 1% CREAM 3 | $258.5K | 8 |
| PRODUCT CODE - 86658291 CLOTRIMAZOLE 1%CREAM 3 GM. TUBE (CANESTEN CREAM 1% 3 G-PH) | $239.3K | 8 |
| CLOTRIMAZOLE 1% (10MG/G) ANTI FUNGAL CRE | $234.1K | 14 |
| CLOTRIMAZOLE 1% CREAM 45GM TUBE WITH 1 A | $223.6K | 12 |
| Product Code : 84008613 CLOTRIMAZOLE 1% | $206.8K | 8 |
| P CODE- 80618964 CLOTRIMAZOLE 2% VAGINA | $175.6K | 10 |
| P CODE - 86658291 - CLOTRIMAZOLE 1% CREAM 3 GM. TUBE CANESTEN CREAM 1% 3 G -PH | $167.7K | 5 |
| P CODE- 80620136 CLOTRIMAZOLE 1% VAGINAL | $167.3K | 5 |
| P CODE- 80620136 CLOTRIMAZOLE 1% VAGINA | $161.0K | 8 |
| CLOTRIMAZOLE 1 % CREAM 45 GM TUBE WITH 1 | $157.3K | 7 |
Encube Ethicals Private Limited exports 284 distinct Clotrimazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is P CODE- 86658291 CLOTRIMAZOLE 1% CREAM 3 with 8 shipments worth $258.5K.
Regulatory Requirements: Exporting Clotrimazole to Key Markets
What Encube Ethicals Private Limited must comply with to export Clotrimazole to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Encube Ethicals Private Limited Compare to Nearest Clotrimazole Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CAPLIN POINT LABORATORIES LIMITED | $12.0M | 302 | 9 | $39.8K |
| 2 | ENCUBE ETHICALS PRIVATE LIMITED ★ | $10.0M | 616 | 10 | $16.2K |
| 4 | S KANT HEALTHCARE LIMITED | $7.2M | 178 | 13 | $40.4K |
| 5 | S K AGE EXPORTS | $6.8M | 163 | 14 | $41.7K |
Encube Ethicals Private Limited ranks #2 among 712 Indian Clotrimazole exporters. Average shipment value of $16.2K compared to the market average of $82.1K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and S KANT HEALTHCARE LIMITED.
Which Indian Ports Ship Clotrimazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,379 | 13.7% |
| SAHAR AIR | 1,261 | 12.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,130 | 11.3% |
| JNPT/ NHAVA SHEVA SEA | 939 | 9.4% |
| JNPT | 636 | 6.3% |
| DELHI AIR CARGO ACC (INDEL4) | 517 | 5.2% |
| DELHI AIR | 380 | 3.8% |
| Bombay Air | 358 | 3.6% |
What Other Antifungals Products Does Encube Ethicals Private Limited Export?
Encube Ethicals Private Limited also exports these antifungals products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Encube Ethicals Private Limited's Clotrimazole Exports
Encube Ethicals' export operations are influenced by a complex interplay of geopolitical events and international trade policies. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Encube, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.
Conversely, the U.S.-China trade tensions have created opportunities for Indian pharmaceutical companies to capture a larger share of the U.S. market. Encube, with its FDA-approved facilities and established presence in the U.S., is well-positioned to leverage this shift. Additionally, the India-European Union Free Trade Agreement (FTA), concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, thereby enhancing market access for Indian exporters. However, compliance with the EU's stringent regulatory standards, including the Falsified Medicines Directive, remains a critical factor for success in this market.
Encube Ethicals Private Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Encube Ethicals. The company's adherence to FDA, WHO, and EU Good Manufacturing Practices (GMP) ensures the quality and safety of its products, facilitating access to global markets. The evolving regulatory landscape, particularly in the EU, necessitates continuous investment in quality systems and processes. For instance, the EU's requirement for analytical testing of every batch at the port of destination can delay market entry by two to three months. Proactive engagement with regulatory bodies and investment in compliance infrastructure are essential for mitigating such challenges.
About Encube Ethicals Private Limited
Encube Ethicals Private Limited exports 11 products worth $57.5M. Beyond Clotrimazole, top products include Clindamycin, Diclofenac, Ketoconazole, Sodium, Miconazole. View the complete Encube Ethicals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clotrimazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clotrimazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Encube Ethicals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 633 individual customs records matching Encube Ethicals Private Limited exporting Clotrimazole, covering 284 formulations to 16 countries via 44 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 158+ countries, 1,728+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clotrimazole Export Data from Encube Ethicals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Encube Ethicals Private Limited's Clotrimazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Encube Ethicals Private Limited
Full Company Profile →
11 products · $57.5M total trade · 9 categories
Clotrimazole Stats
Company Overview
Top Products by Encube Ethicals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Encube Ethicals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clotrimazole. For current shipment-level data, contact TransData Nexus.